Fundraising Fox

Veana Therapeutics

Portland, US · Founded 2015 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

FA
F Andrew RayNamed on SEC filing
MF
Mark F HoliferNamed on SEC filing
EA
Emmanuel AkporiayeNamed on SEC filing
RA
Rebecca AkporiayeNamed on SEC filing
AD
Andrew D ThalerNamed on SEC filing
DR
Denis R BurgerNamed on SEC filing
TE
Thomas E McChesneyNamed on SEC filing
TD
Trent D DavisNamed on SEC filing

Investors · 2

Elevate CapitalBeaverton · $2M – $25M
PortfoliaSan Mateo · $10K

Reported raises · per SEC filings

Form D private placements

$1.4M disclosed across 2 rounds · 2018–2020

▶$831KraisedNov 2020 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • EMMANUEL AKPORIAYEExecutive Officer, Director
  • SANDRA SHOTWELLDirector
  • REBECCA AKPORIAYEExecutive Officer, Director
  • BRUCE RAMSEYERDirector
  • ANDREW RAYDirector
Offering amount
$1.3M
Amount sold
$831K
First sale
Oct 2020
Incorporated
Corporation, Delaware, 2015
Federal exemptions
04, 06b
Full filing on SEC EDGAR ↗
▶$542KraisedMay 2018 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • F Andrew RayDirector
  • Mark F HoliferExecutive Officer, Director, Promoter
  • Emmanuel AkporiayeExecutive Officer, Director, Promoter
  • Rebecca AkporiayeExecutive Officer, Director
  • Andrew D ThalerExecutive Officer
  • Denis R BurgerDirector
  • Thomas E McChesneyExecutive Officer
  • Trent D DavisDirector
Offering amount
$2M
Amount sold
$542K
Minimum investment
$5K
Proceeds to insiders
$100K
First sale
May 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2021$400K
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$350.1K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Veana Therapeutics SERIES SEED-2A - CANCER FUNDcancerfund.com · May 2024OBI & OTRADI February 2022 Newsletter - OTRADIotradi.org · Feb 2022Portland immunotherapy startup tops $10M in funding as it launches first clinical trial – GeekWiregeekwire.com · May 2018Veana Therapeutics Appoints Denis R. Burger, Ph.D. to Board of Directorsfinance.yahoo.com · Dec 2017

Frequently asked questions

Who are Veana Therapeutics's investors?
Veana Therapeutics's investors include Elevate Capital, Portfolia.
How much funding has Veana Therapeutics raised?
Veana Therapeutics has disclosed $1.4M raised across 2 rounds.
Where is Veana Therapeutics headquartered?
Veana Therapeutics is headquartered in Portland, US.